May 22, 2026 03:09AM
May 22, 2026 03:09AM
Apr 13, 2026 04:35AM
Apr 13, 2026 04:34AM
Dec 24, 2025 09:05PM
Dec 24, 2025 09:05PM
Aug 12, 2025 04:20AM Caliway added to MSCI index, receives Health Canada study approval
Aug 12, 2025 04:19AM
Jul 28, 2025 05:52AM
Jul 28, 2025 05:51AM
Jun 10, 2025 04:15AM
May 14, 2025 01:38AM
Apr 17, 2025 06:34AM
Mar 12, 2025 02:29AM Caliway's CBL-514 Phase 2 Study (CBL-0202) Accepted for Publication in the Aesthetic Surgery Journal
Feb 10, 2025 01:15AM
Dec 18, 2024 09:47PM
Dec 11, 2024 09:53AM
Nov 12, 2024 08:25AM
Oct 23, 2024 10:28AM
Sep 3, 2024 03:18AM
Apr 25, 2024 01:25PM Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints
Mar 3, 2024 06:00PM
Feb 14, 2024 07:56PM
Jan 23, 2024 05:35AM
Jan 8, 2024 12:25AM
Dec 16, 2023 02:47AM
Oct 2, 2023 09:00AM
Jun 28, 2023 06:30AM Caliway Announces Positive Data from CBL-0201EFP Phase 2-Stage 1 Study of CBL-514 in Treating Moderate to Severe Cellulite
May 31, 2023 08:15AM

324,757 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All